Quality of Life With Pembrolizumab for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040
Journal of the National Cancer Institute ; doi:10.1093/jnci/djaa063
The publisher has not yet granted permission to display this abstract.
Keywords: HRQoL / Pembrolizumab / HNSCC / chemotherapy / standard of care
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Journal of the National Cancer Institute" .